Duration of Contact Precautions in Acute Care Settings

Publication Date: February 1, 2018

Key Points

Key Points

This expert guidance document provides recommendations regarding discontinuation of contact precautions (CP) at the individual patient level in acute-care hospitals employing CP for 1 or more of the following organisms: methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), Clostridium difficile (CDI), and multidrug-resistant Enterobacteriaceae (MDR-E), including carbapenem-resistant Enterobacteriaceae (CRE) and extended-spectrum β-lactamase (ESBL)–producing organisms.

Recommendations herein are based on synthesis of limited evidence, theoretical rationale, current practices, practical considerations, the opinion of the writing group, consideration of potential harms, and a survey of 134 institutions within the SHEA Research Network, 26% of which are outside the United States and Canada.

Methicillin-Resistant Staphylococcus aureus (MRSA)

...thicillin-Resistant Staphylococcus aureus (MRSA)...

If a hospital uses CP for patients previousl...


...ients not on antimicrobial therapy with a...


...or high-risk patients, such as those w...


Outside an outbreak setting, if a fac...


Vancomycin-Resistant Enterococci (VRE)

...comycin-Resistant Enterococci (VRE)...

...l uses CP when caring for patients coloniz...


...s that, following treatment of VRE i...


...pitals should consider extending CP prio...


...an outbreak setting and if facility endemic rate...


Multidrug-Resistant Enterobacteriaceae (MDR-E)

...Resistant Enterobacteriaceae (M...

...hospital uses CP for patients infected...


...mends that for extensively drug-resistant En...


Clostridium difficile

...stridium diffici...

...ecommends that patients with C. diffici...


...itals should consider extending CP t...


At this time, insufficient evidence exis...


Microbiological Screening and Molecular Testing

...iological Screening and Molecular Testing...

...this time, insufficient evidence exists...